Tesamorelin 2 Milligrams (MG)
IRB00110936-2
Phase 2 small_molecule active
Quick answer
Tesamorelin 2 Milligrams (MG) for Peripheral Nerve Injuries is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Peripheral Nerve Injuries
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active